Since the IFN-response pathway can inhibit tumorigenesis through indirect effects on the tumor microenvironment [29], we propose that high STAT3 levels in GICs may inhibit these IFN-response genes and promote GBM tumorigenesis. Here, STAT3 is linked to neoplasm.